UK markets closed
NIKKEI 225
27,518.25 +41.38 (+0.15%) HANG SENG
19,784.65 +216.96 (+1.11%) CRUDE OIL
73.86 +1.05 (+1.44%) GOLD FUTURES
1,973.40 +19.60 (+1.00%) DOW
32,390.46 -41.62 (-0.13%) Bitcoin GBP
21,787.34 -96.42 (-0.44%)
Aeglea BioTherapeutics, Inc. (AGLE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:27PM EDT. Market open.
| Previous close | 0.3051 |
| Open | 0.3101 |
| Bid | 0.3009 x 4000 |
| Ask | 0.3100 x 1200 |
| Day's range | 0.3008 - 0.3179 |
| 52-week range | 0.3000 - 3.1700 |
| Volume | |
| Avg. volume | 317,783 |
| Market cap | 19.684M |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0500 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.50 |
- Zacks
Aeglea Biotherapeutics (AGLE) Reports Q4 Loss, Lags Revenue Estimates
Aeglea (AGLE) delivered earnings and revenue surprises of 10% and 1.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) insiders placed bullish bets worth US$695k in the last 12 months
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
- Simply Wall St.
Here's Why Aeglea BioTherapeutics (NASDAQ:AGLE) Must Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although...
© 2023 Yahoo. All rights reserved.
